Mesenchymal stem cells as a vector for the inflammatory prostate microenvironment
about
Aberrant Transforming Growth Factor-β Activation Recruits Mesenchymal Stem Cells During Prostatic Hyperplasia.Pharmacokinetics and toxicology of a fibroblast activation protein (FAP)-activated prodrug in murine xenograft models of human cancer.PARP-1 regulates epithelial-mesenchymal transition (EMT) in prostate tumorigenesisBeyond the androgen receptor: new approaches to treating metastatic prostate cancer. Report of the 2013 Prouts Neck Prostate Cancer MeetingThe host microenvironment influences prostate cancer invasion, systemic spread, bone colonization, and osteoblastic metastasis.Mesenchymal stem cells expressing interleukin-18 suppress breast cancer cells in vitro.Cancer exosomes trigger mesenchymal stem cell differentiation into pro-angiogenic and pro-invasive myofibroblastsFibroblast activation protein-α, a stromal cell surface protease, shapes key features of cancer associated fibroblasts through proteome and degradome alterationsThe role of mesenchymal stem cells in promoting the transformation of androgen-dependent human prostate cancer cells into androgen-independent mannerEffect of mesenchymal stem cell transplantation on brain-derived neurotrophic factor expression in rats with Tourette syndrome.A prodrug-doped cellular Trojan Horse for the potential treatment of prostate cancer.Rapid selection of mesenchymal stem and progenitor cells in primary prostate stromal culturesBone mesenchymal stem cells differentiate into myofibroblasts in the tumor microenvironment.Systemic Immune-Inflammation Index Predicts the Clinical Outcome in Patients with mCRPC Treated with Abiraterone.Assessing angiogenic responses induced by primary human prostate stromal cells in a three-dimensional fibrin matrix assay.The Multifaceted Roles of STAT3 Signaling in the Progression of Prostate Cancer.Delivery of improved oncolytic adenoviruses by mesenchymal stromal cells for elimination of tumorigenic pancreatic cancer cells.Mesenchymal stem cell infiltration during neoplastic transformation of the human prostate.SERCA control of cell death and survival.Intravenous Infusion of Bone Marrow-Derived Mesenchymal Stem Cells Reduces Erectile Dysfunction Following Cavernous Nerve Injury in Rats.Bone marrow-derived cells contribute to regeneration of injured prostate epithelium and stroma.Repeated stimulation by LPS promotes the senescence of DPSCs via TLR4/MyD88-NF-κB-p53/p21 signaling.Targeting the tumour stroma to improve cancer therapy.Prostate chronic inflammation type IV and prostate cancer risk in patients undergoing first biopsy set: Results of a large cohort study.Using high throughput microtissue culture to study the difference in prostate cancer cell behavior and drug response in 2D and 3D co-cultures.Mesenchymal stem cells recruited by castration-induced inflammation activation accelerate prostate cancer hormone resistance via chemokine ligand 5 secretionConcise Review: Mesenchymal Stem Cell-Based Drug Delivery: The Good, the Bad, the Ugly, and the Promise
P2860
Q33722426-8AFF3A2F-4B68-4F47-8F4A-9D7A76AF084BQ34037014-D343127E-01DA-4EB5-ACEB-64AFE7DC635CQ34434937-FE02D3C5-5A46-4714-BF5E-9F522F3F4A15Q34617627-F245BF38-62AA-4DEF-969B-14FD07638048Q34699785-8D3DDF78-13E2-4984-9A1D-A04E2E67D8BCQ35159519-CFD75561-9F2D-4592-9C04-34D705F1DB8BQ35176121-63209235-B512-4B7A-BBF4-DC0F5DE674F5Q35754294-AFDE29AB-739A-42C1-A251-DB074AA9DF05Q36501020-34266CB9-6053-4B6C-B1E2-03EBC539637BQ36741411-FBF61255-A510-4115-924B-B0A237843C04Q36776738-69896467-0DCE-4B33-85A0-5AF50952EF4BQ36867662-39E64B7B-D989-4545-8C70-D84665F1BC48Q37002808-834DBF6C-E021-450F-9690-1E70CA8F07CBQ37335554-A7CCB8FA-8A04-4851-92D8-26C77937D2FDQ37687607-24B986E0-865A-4D82-8275-7028E3E28B5EQ38203779-AFFAD22A-266A-462A-BBB7-009A22A096BFQ38914555-1E5F9736-DDC8-4619-86F9-A30D18050EF6Q41470722-0968868B-915A-477A-86B1-8D36C1F8B5A0Q46330392-2A00657E-46B0-4CDC-B32D-C0706AADB6AAQ47257811-01B798B4-FA93-4A7A-91E5-25A5D430F6AAQ50439925-8AECA75C-FBF0-412E-8FC5-F0B0C043EEA6Q51738168-7CB6750E-0A05-465B-995C-7BB2CDB22A95Q52322982-14B18AB2-5027-42BD-A64B-D3158633A8CCQ54945681-B37BD930-D906-4462-AA01-B6262E046C75Q55317401-A8344764-1399-409D-8B1D-6C793562160EQ58694827-6A3D6AA7-C350-4B51-84A6-68D7932430D2Q58804653-57D1A22D-50DE-44B5-8518-73BB1CA99294
P2860
Mesenchymal stem cells as a vector for the inflammatory prostate microenvironment
description
2013 nî lūn-bûn
@nan
2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Mesenchymal stem cells as a vector for the inflammatory prostate microenvironment
@ast
Mesenchymal stem cells as a vector for the inflammatory prostate microenvironment
@en
Mesenchymal stem cells as a vector for the inflammatory prostate microenvironment
@nl
type
label
Mesenchymal stem cells as a vector for the inflammatory prostate microenvironment
@ast
Mesenchymal stem cells as a vector for the inflammatory prostate microenvironment
@en
Mesenchymal stem cells as a vector for the inflammatory prostate microenvironment
@nl
prefLabel
Mesenchymal stem cells as a vector for the inflammatory prostate microenvironment
@ast
Mesenchymal stem cells as a vector for the inflammatory prostate microenvironment
@en
Mesenchymal stem cells as a vector for the inflammatory prostate microenvironment
@nl
P2093
P2860
P3181
P356
P1476
Mesenchymal stem cells as a vector for the inflammatory prostate microenvironment
@en
P2093
J. T. Isaacs
S. R. Denmeade
W. N. Brennen
P2860
P304
P3181
P356
10.1530/ERC-13-0151
P407
P577
2013-10-01T00:00:00Z